JPRN-UMIN000021591已完成未知
The pilot study of Nintedanib and Carboplatin plus Paclitaxel for advanced non-small cell lung cancer with idiopathic interstitial pneumonia - The pilot study of Nintedanib and Carboplatin plus Paclitaxel for advanced non-small cell lung cancer with idiopathic interstitial pneumonia
Hirosaki University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2016年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Uncotrollable angiona pectorias, cardian infarction, haear failure, diabetes mellitus, hypertension 2) Using prednisolone >10mg/day 3) Active infection 4) Active double cancers 5) symptomatic brain metastasis 6) Patients with uncontrolled pleural or pericardial effusion, or ascites 7) pregnancy 8) Patient with a history of allergy to CBDCA, PTX and nintedanib 9) Inappropriate patients in this study
研究者
相似试验
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
招募中
1 期
Phase I/II study of Carboplatin plus Nab-Paclitaxel in patients with advanced non-small-cell lung cancer and a performance status of 2on-small-cell lung cancerJPRN-UMIN000014544Shizuoka cancer center33
进行中（未招募）
2 期
A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasACTRN12616000958482Australasian Gastro-Intestinal Trials Group (AGITG)60
已完成
1 期
Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal CancerColon AdenocarcinomaRectal AdenocarcinomaRecurrent Colon CarcinomaRecurrent Rectal CarcinomaStage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Rectal CancerNCT02393755Roswell Park Cancer Institute42
已完成
2 期
Randomized Phase 2 study of Nintedanib and Pirfenidone versus Nintedanib following a clinically meaningful decline in forced vital capacity in patients with idiopathic pulmonary fibrosis administering pirfenidoneidiopathic pulmonary fibrosisJPRN-UMIN000019436Kanagawa Cardiovascular and Respiratory Center60